BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
(NASDAQ: BIVI) Delayed: 1.94 +0.18 (10.23%)
Previous Close $1.76    52 Week High $0.40 
Open $1.79    52 Week Low $0.17 
Day High $2.12    P/E N/A 
Day Low $1.86    EPS $0.00 
Volume 693,206